Iradimed Profit Margin

Iradimed (IRMD) currently reports a profit margin of 26.7% as of June 2026. That compares with 26.61% in the prior-year period — up 0.4% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore Iradimed's profit margin history and peer comparisons.

Iradimed's profit margin increased from 26.61% to 26.7% — a 0.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Iradimed's profit margin of 26.7% is higher than the Healthcare sector average of 13.89%. That is roughly 92.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Iradimed's current 26.7% should be judged against Healthcare norms (sector average: 13.89%) and against IRMD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 26.7%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Iradimed, and consider following IRMD for alerts when major investors trade the stock.